Harvey C Barnum JR
CIK 1480680 · View on SEC EDGAR ↗
First SEC filing: March 14, 2013 · Latest: March 14, 2013
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2015 | MED | A | 1,250 | — | — | 6,250 Direct | +25.00% | Acquired | (price as of 2026-08-21) |
| Feb. 17, 2015 | MED | A | 315 | — | — | 8,742 Direct | +3.74% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2014 | MED | A | 305 | — | — | 8,427 Direct | +3.76% | Acquired | (price as of 2026-08-21) |
| Sept. 30, 2014 | MED | A | 311 | — | — | 8,122 Direct | +3.98% | Acquired | (price as of 2026-08-21) |
| June 30, 2014 | MED | A | 336 | — | — | 7,811 Direct | +4.49% | Acquired | (price as of 2026-08-21) |
| March 31, 2014 | MED | A | 351 | — | — | 7,475 Direct | +4.93% | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2014 | MED | A | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2014 | MED | A | 750 | — | — | 7,124 Direct | +11.77% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2013 | MED | A | 391 | — | — | 6,374 Direct | +6.54% | Acquired | (price as of 2026-08-21) |
| Sept. 30, 2013 | MED | A | 379 | — | — | 5,983 Direct | +6.76% | Acquired | (price as of 2026-08-21) |
| June 30, 2013 | MED | A | 396 | — | — | 5,604 Direct | +7.60% | Acquired | (price as of 2026-08-21) |
| March 31, 2013 | MED | A | 456 | — | — | 5,208 Direct | +9.60% | Acquired | (price as of 2026-08-21) |
| Feb. 19, 2013 | MED | A | 750 | — | — | 4,752 Direct | +18.74% | Acquired | (price as of 2026-08-21) |
| June 20, 2011 | MED | A | 1,482 | $22.40 | $33,197 | 2,048 Direct | +261.84% | Acquired | -47.5% (price as of 2026-08-21) |
| April 6, 2010 | MED | A | 566 | $26.52 | $15,010 | 566 Direct | — | Acquired | -55.7% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 17, 2015 | MED | Stock Option | Common Stock (1,250) | $31.55 | Feb. 17, 2025 | 1,250 | Acquired |
| Feb. 5, 2014 | MED | Stock Option | Common Stock (5,000) | $26.52 | Feb. 5, 2024 | 5,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).